Physician profile
Dennis A Thompson
NPI 1326151655
$10,036.08
in general payments reported to CMS, 2019-2025
47 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what 94% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $1,166 · 2021: $1,507 · 2022: $1,353 · 2023: $1,375 · 2024: $1,603 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,004.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,850.11 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $960.09 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $910.77 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $749.14 | 2021-2025 | Vraylar, Ubrelvy |
| Pfizer INC. | $694.85 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $478.19 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $363.72 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $317.55 | 2019-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.43 | 2019-2025 | Jardiance |
| Amgen INC. | $297.35 | 2019-2025 | Repatha, Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $285.94 | 2019-2023 | |
| Amarin Pharma, INC. | $257.75 | 2019-2023 | |
| Abbott Laboratories | $253.26 | 2019-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $227.45 | 2021 | |
| Janssen Pharmaceuticals, INC | $213.69 | 2019-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.